8 Recruiting Alzheimer's Disease Phase 2 Clinical Trials
Active phase 2 studies for alzheimer's disease enrolling across the USA. Verify eligibility and contact site coordinators.
All Alzheimer's Disease studiesPhase 2 Studies for Alzheimer's Disease
🔵 Active, Not Recruiting Phase2
A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease
📍 Banner Sun Health Research — Phoenix, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease
📍 GSK Investigational Site — San Diego, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 / Phase3
Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease
📍 ATP Clinical Research — Costa Mesa, California
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase2 / Phase3
A Phase 2b/3 Clinical Study Evaluating T3D-959 in Mild-to-Moderate Alzheimer's Disease Subjects
📍 T3D Therapeutics, Inc. — Durham, North Carolina
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase2
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
📍 National Institute of Aging, Clinical Research Unit — Baltimore, Maryland
View Study & Checklist ➔ 🟢 Recruiting Phase2
Open-label Extension Study in Participants With Early Alzheimer's Disease
📍 GSK Investigational Site — Maitland, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase2
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
📍 Banner Alzheimers Institute — Phoenix, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
📍 Irvine Center for Clinical Research /ID# 277752 — Irvine, California
View Study & Checklist ➔